Want to see FTH full AI Analyst Report?
Faeth Therapeutics (FTH) Ownership Overview
5.14% Insiders
0.26% Mutual Funds
46.62% Other Institutional Investors
1.83% ETFs
46.15% Public Companies and
Individual Investors
The ownership structure of Faeth Therapeutics (FTH) stock is a mix of institutional, retail, and individual investors. Approximately 48.71% of the company’s stock is owned by Institutional Investors, 5.14% is owned by Insiders, and 46.15% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jul 01, 2026 | xxxxxxxxxxxxx | $326127 | |
Jun 26, 2026 | xxxxxxxxxxxxx | $401269 | |
Jun 24, 2026 | xxxxxxxxxxxxx | $405921 | |
Jun 24, 2026 | xxxxxxxxxxxxx | $55447 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2026 | xxxxxxxxxxxxx | $32160275 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $18050500 | |
Jun 30, 2026 | xxxxxxxxxxxxx | $18050500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,286,411 | Institution | 4.98% | 29,909,056 | |
| 817,699 | Insider | 3.16% | 19,011,502 | |
| 722,020 | Institution | 2.79% | 16,786,965 | |
| 722,020 | Institution | 2.79% | 16,786,965 | |
| 361,010 | Institution | 1.40% | 8,393,483 | |
| 217,292 | Institution | 0.84% | 5,052,039 | |
| 133,986 | Insider | 0.52% | 3,115,175 | |
| 130,142 | Insider | 0.50% | 3,025,802 | |
| 130,142 | Insider | 0.50% | 3,025,802 | |
| 114,654 | Institution | 0.44% | 2,665,706 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 48,771 | Institution | 0.19% | 1,133,926 | |
| 8,986 | Institution | 0.03% | 208,925 | |
| 7,750 | Institution | 0.03% | 180,188 | |
| 1,892 | Institution | <0.01% | 43,989 | |
| 369 | Institution | <0.01% | 8,579 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 220,244 | Institution | 0.85% | 5,732,951 | |
| 102,243 | Institution | 0.40% | 2,661,385 | |
| 77,074 | Institution | 0.30% | 1,791,971 | |
| 29,382 | Institution | 0.11% | 683,132 | |
| 12,411 | Institution | 0.05% | 323,058 | |
| 10,115 | Institution | 0.04% | 331,469 | |
| 9,115 | Institution | 0.04% | 237,263 | |
| 4,772 | Institution | 0.02% | 124,215 | |
| 556 | Institution | <0.01% | 12,927 | |
| 63 | Institution | <0.01% | 1,640 |
FAQ
Who Owns Faeth Therapeutics (FTH)?
According to the latest TipRanks data, approximately 46.62% of the company's stock is held by institutional investors, 5.14% is held by insiders, and 46.15% is held by retail investors.
What percentage of Faeth Therapeutics (FTH) stock is held by institutional investors?
According to the latest TipRanks data, approximately 46.62% of Faeth Therapeutics (FTH) stock is held by institutional investors.
What percentage of Faeth Therapeutics (FTH) stock is held by retail investors?
According to the latest TipRanks data, approximately 46.15% of Faeth Therapeutics (FTH) stock is held by retail investors.
Who owns the most shares of Faeth Therapeutics (FTH)?
Felix Baker owns the most shares of Faeth Therapeutics (FTH).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.